4-Bromo-6-methoxypyrimidine

Catalog No. :
ACQCIG467
CAS No. :
69543-97-1
Molecular Formula :
C5H5BrN2O
Molecular Weight :
189.01

IUPAC Name:4-bromo-6-methoxypyrimidine

4-Bromo-6-methoxypyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$56.00Login to see priceIn stockInquiry
1g97%$152.00Login to see priceIn stockInquiry
5g97%$444.00Login to see priceIn stockInquiry
10g97%$739.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromo-6-methoxypyrimidine
IUPAC Name4-bromo-6-methoxypyrimidine
MDL No.MFCD14702773
Molecular FormulaC5H5BrN2O
Molecular Weight189.01
SMILESCOC1=NC=NC(Br)=C1
InChI KeyOHIQMDUOTBJERV-UHFFFAOYSA-N
Synonym4-Bromo-6-methoxypyrimidine | 69543-97-1 | 4-bromo-6-(trideuteriomethoxy)pyrimidine | SCHEMBL22412860 | DTXSID50743657 | AMY16417 | MFCD14702773 | AKOS016005697 | CS-W019069 | MB14215 | DS-15710 | FT-0726706 | C76202 | EN300-374321
CAS No.69543-97-1
PubChem CID70700864

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACQCIG467 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACGIYB270 route compound structure diagram
    ACGIYB270126401-90-9 In Stock
  4. Then
  5. ACQCIG467 route product structure diagram
    ACQCIG46769543-97-1 In Stock
Inquiry

2. ACQCIG467 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACGIYB270 route compound structure diagram
    ACGIYB270126401-90-9 In Stock
  4. Then
  5. ACQCIG467 route product structure diagram
    ACQCIG46769543-97-1 In Stock
Inquiry

Comments (0)